Publication Cover
Materials Technology
Advanced Performance Materials
Volume 37, 2022 - Issue 11
263
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Incorporation of Boswellia sacra essential oil into chitosan/TPP nanoparticles towards improved therapeutic efficiency

, , , , &
Pages 1703-1715 | Received 22 Jun 2021, Accepted 29 Aug 2021, Published online: 08 Sep 2021
 

ABSTRACT

The aim of this survey was to fabrication of chitosan nanoparticle was loaded by Boswellia sacra essential oil (BS-CNPs) and investigation of its pharmacological activities.BS-CNPs was synthesized by ionic gelation method and characterized. BS-CNPs-mediated cell viability and cell death were studied by MTT, qPCR, AO/PI staining and flow cytometery. Anti-angiogenesis properties were evaluated by CAM and scratch assay. Anti-oxidant properties were assessed by ABTS, DPPH, FRAP and ROS assay. The BS-CNPs (80.13 nm, ζ-p 39.20 mv and %EE: 82.7%) exhibited selective cytotoxicity on HepG2 cells (IC50:62.94 μg/ml). BS-CNPs induced the apoptosis by up-regulation of P53, Cas-3 and 9. Increasing the rate of free radical scavenging and intracellular ROS confirmed the anti and pro-oxidant potential of BS-CNPs outside and inside of cancer cells.Inhibition (92.3%) of cell migration, reduction of angiogenic factors showed anti-angiogenic effects of BS-CNPs.BS-CNPs due tounique anti-cancer properties are suitable for therapeutic targets in cancer studies.

Acknowledgments

The authors very much appreciate the support provided by the Islamic Azad University, Mashhad, Iran, in the conducting of the present research.

Disclosure statement

The authors have declared no conflict of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.